ArticleCardiovascular drugs and therapy2025

Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis.

Bozhi Ye et al.PubMed ↗Publisher ↗

No numbers read from the abstract.